Which therapeutic classification does Irbesartan belong to?

Which therapeutic classification does Irbesartan belong to?

• A. Calcium Channel Blocker
• B. Angiotensin II Receptor Antagonist
• C. Diuretic
• D. Beta Blocker

Answer: (B)

Irbesartan is classified as an Angiotensin II Receptor Antagonist, which is a therapeutic classification focused on the management of blood pressure and heart failure. This class of medications works by blocking the effects of angiotensin II, a hormone that causes blood vessels to constrict, thereby leading to increased blood pressure. By blocking this action, Irbesartan helps to relax and widen blood vessels, resulting in lower blood pressure and reduced workload on the heart. This mechanism is particularly beneficial for patients with hypertension, as well as for those with renal issues related to diabetes, as it can also help protect kidney function. The specificity of Irbesartan in targeting the angiotensin II receptors distinguishes it from other drug classes such as calcium channel blockers, diuretics, and beta blockers, which work through different mechanisms and are used for varying therapeutic purposes in cardiovascular care.

Irbesartan is classified as an Angiotensin II Receptor Antagonist, which is a therapeutic classification focused on the management of blood pressure and heart failure. This class of medications works by blocking the effects of angiotensin II, a hormone that causes blood vessels to constrict, thereby leading to increased blood pressure. By blocking this action, Irbesartan helps to relax and widen blood vessels, resulting in lower blood pressure and reduced workload on the heart.

This mechanism is particularly beneficial for patients with hypertension, as well as for those with renal issues related to diabetes, as it can also help protect kidney function. The specificity of Irbesartan in targeting the angiotensin II receptors distinguishes it from other drug classes such as calcium channel blockers, diuretics, and beta blockers, which work through different mechanisms and are used for varying therapeutic purposes in cardiovascular care.